Photodynamic inactivation of virus was tested as a potential therapeutic tool for herpesvirus-induced keratitis, which is a leading cause of blindness and disability. Experimental keratitis produced in rabbits by infection with herpesvirus isolated from a human periorbital lesion was treated with proflavine and light. The herpetic keratitis could be rapidly resolved by the dye-light treatment, whereas improvement was not seen in untreated rabbits, nor in those treated with light alone or dye alone.
During 1963 to 1969, Wallis and Melnick (4, 5, [7] [8] [9] [10] comprehensively delineated the parameters for irreversible photosensitization of entero-and other viruses. They reviewed (6) Treatment. A stock of 1% proflavine sulfate (Allied Chemical Corp., no. NA 0115) was made in physiological saline and sterilized by filtration through a 0.22-,gm membrane (Millipore Corp.). The sterile product was stored in amber bottles. Rabbits were treated with 0.1 ml of the dye three times daily at intervals of 1 hr. Two hours after the last dose, eyes were exposed to light (150-watt incandescent bulb, at a distance of 3 ft) for 5 min; 2 hr later, a repeat light treatment was performed as described. Dye and light treatment was carried out on the second day when severe herpetic keratitis was manifest, and was repeated on the following day. Preliminary experiments showed that additional dye or light treatments were of no avail.
RESULTS
Titration of herpesvirus in rabbit corneas. Serially diluted herpesvirus was inoculated into scarified eyes, and the subsequent degree of keratitis was scored. Resulting encephalitis due to virus infection was also recorded. The results in Table 1 show that the severest keratitis obtained without fatalities was with a dose of 104 PFU/rabbit cornea. Therefore, all experiments described hereafter were carried out with this virus concentration.
Titration of proflavine. Rabbits scarified and inoculated with virus (104 PFU/cornea) were treated with dye and light as described above. Four different concentrations of dye were used as shown in Table 2 . From these results, 0.1% dye was found to be the highest dilution which gave striking therapeutic relief. To use as dilute a dye as possible (to preclude toxicity) and still obtain marked clinical benefit, this concentration of dye was used in subsequent experiments.
Effects of light or dye or both on keratitis. The corneas of 54 rabbits were scarified and inoculated with virus; 48 hr later, 48 rabbits (96 eyes) manifested severe herpetic keratitis. The other rabbits failed to manifest bilaterally severe lesions and were not used. The 48 rabbits were randomized and treated by the procedures described in Table 3 .
Of 24 corneas treated with dye and light, 22 were completely cured on the 10th day. The improvement and cure of keratitis in these rabbits was rapid, starting on the 3rd day after treatment; by the 6th day, 15 rabbits were either cured or almost cured. On the other hand, rabbits treated only with dye and no direct light exposure showed a total of six cures of 24 corneas on the 10th day. Similarly, corneas treated with light and no dye or untreated corneas (no dye or light) failed to improve in significant numbers. PFU of herpesvirus were inoculated into each eye. Two days later, all inoculated corneas that exhibited ++++ lesions were treated with dye and exposed to light. Dye was then administered three times daily for two days. The scoring of keratitis is the same as in Table 1 . F3TDR (trifluorothymidine), MADU (5-methylamino-2'-deoxyuridine), EDU (5-ethyl-2'-deoxyuridine), and morgalin (N1lanhydro-bis-beta hydroxylethyl biguanide hydrochloride). Although some of these drugs have some degree of antiviral activity, there is still a need for effective treatment for herpetic infections of the eye (3). It would seem worthwhile to extend our present results from the laboratory to the clinic.
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